Technical Analysis for LUNG - Pulmonx Corporation

Grade Last Price % Change Price Change
D 59.37 -0.67% -0.40
LUNG closed down 0.67 percent on Friday, January 15, 2021, on 64 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Up Down
Historical LUNG trend table...

Date Alert Name Type % Chg
Doji - Bullish? Reversal 0.00%
Multiple of Ten Bearish Other 0.00%
Fell Below 20 DMA Bearish -0.67%
Multiple of Ten Bearish Other -0.67%
Outside Day Range Expansion -0.67%
Wide Bands Range Expansion -0.67%
Wide Bands Range Expansion -3.90%
Narrow Range Bar Range Contraction -3.90%
NR7 Range Contraction -3.90%
Inside Day Range Contraction -3.90%
Older End-of-Day Signals for LUNG ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
10 DMA Resistance 1 day ago
Down 3% 1 day ago
Down 2 % 1 day ago
Down 1% 1 day ago
Fell Below Previous Day's Low 1 day ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Pulmonx Corporation Description

Pulmonx Corporation, a medical technology company, designs, develops, manufactures, and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. It serves emphysema patients in Europe, the Middle East, Africa, the Asia-Pacific, the United States, and internationally. Pulmonx Corporation was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. The company was incorporated in 1995 and is headquartered in Redwood City, California.


Sector: Other
Industry: Other
Keywords: Medicine Clinical Medicine Medical Technology Catheter Inflation Pulmonary Disease Chronic Obstructive Pulmonary Disease Tomography Pulmonology Balloon Catheter Chronic Obstructive Pulmonary Diseases Treatment Of Chronic Obstructive Pulmonary Disease Invasive Medical Devices Lung Minimally Invasive Medical Devices Valves

Is LUNG a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 69.48
52 Week Low 37.64
Average Volume 251,419
200-Day Moving Average 0.00
50-Day Moving Average 53.79
20-Day Moving Average 60.70
10-Day Moving Average 60.24
Average True Range 4.32
ADX 23.53
+DI 22.92
-DI 20.81
Chandelier Exit (Long, 3 ATRs ) 56.54
Chandelier Exit (Short, 3 ATRs ) 58.70
Upper Bollinger Band 69.23
Lower Bollinger Band 52.17
Percent B (%b) 0.42
BandWidth 28.11
MACD Line 2.07
MACD Signal Line 2.71
MACD Histogram -0.6435
Fundamentals Value
Market Cap 2.12 Billion
Num Shares 35.7 Million
Price-to-Sales 52.65
Price-to-Book 41.01
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 63.97
Resistance 3 (R3) 63.69 61.88 63.20
Resistance 2 (R2) 61.88 60.71 62.02 62.95
Resistance 1 (R1) 60.63 59.99 61.26 60.90 62.69
Pivot Point 58.82 58.82 59.13 58.96 58.82
Support 1 (S1) 57.56 57.65 58.19 57.84 56.05
Support 2 (S2) 55.75 56.92 55.89 55.79
Support 3 (S3) 54.50 55.75 55.54
Support 4 (S4) 54.77